Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Lensar Inc (LNSR)

Lensar Inc (LNSR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
LENSAR® Reports Third Quarter 2025 Results and Provides Business Update

18 ALLY Robotic Cataract Laser Systems ® (“ALLY Systems”) placed in 3Q 2025; Backlog of 18 ALLY Systems pending installation as of September 30, 2025 ALLY installed base grew 77% and total...

LNSR : 11.95 (+2.22%)
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ORLANDO, Fla., Sept. 02, 2025 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR’s board of directors...

LNSR : 11.95 (+2.22%)
LENSAR Reports Second Quarter 2025 Results and Provides Business Update

18 ALLY Robotic Cataract Laser Systems™ (“ALLY Systems”) placed in 2Q 2025 with an additional backlog of 18 ALLY Systems pending installation as of June 30, 2025 ALLY installed base grew 107%...

LNSR : 11.95 (+2.22%)
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

LNSR : 11.95 (+2.22%)
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

LNSR : 11.95 (+2.22%)
LENSAR Reports First Quarter 2025 Results and Provides Business Update

LNSR : 11.95 (+2.22%)
Alcon Agrees to Acquire LENSAR, Inc.

LNSR : 11.95 (+2.22%)
ALC : 84.13 (+1.54%)
LENSAR - Top Healthcare Equipment Stock

Summary LENSAR (LNSR) has shown strong technical buy signals, high Weighted Alpha, and consistent price appreciation, gaining 16.65% since the Trend Seeker buy signal on 2/28.. The company specializes...

LNSR : 11.95 (+2.22%)
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

LNSR : 11.95 (+2.22%)
LENSAR Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update

31 ALLY Robotic Cataract Laser Systems™ placed in Q4 2024, representing an 86% increase in ALLY placements in full year 2024 over 2023; Company’s total installed systems increased to approximately...

LNSR : 11.95 (+2.22%)

Barchart Exclusives

This Blue-Chip Stock Just Slashed Its Dividend by 50%. Should You Run Away Now?
LyondellBasell’s 50% dividend cut shocks income investors, but the move may signal balance-sheet defense rather than long-term weakness. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar